Home Medicine Laboratory medicine in the 2000s: programmed death or rebirth?
Article
Licensed
Unlicensed Requires Authentication

Laboratory medicine in the 2000s: programmed death or rebirth?

  • Gian Cesare Guidi and Giuseppe Lippi
Published/Copyright: July 31, 2006

Abstract

Changes have occurred in the organization, complexity and role of medical laboratories in healthcare, requiring a great increase in global productivity and diagnostic efficiency by enrolled professionals to withstand new challenges. Such a radical evolution, which should be very attractive for new generations of professionals, is counterbalanced by an increasing shortage of laboratory vocations worldwide, particularly in community hospital and large reference laboratories, which may lead to a serious crisis in the field of laboratory medicine in the very near future. Some reasons can be highlighted, including the decreased interaction between clinicians and laboratory professionals, centralized testing, and the development of innovative, minimally invasive techniques that can easily be handled without direct control or supervision by laboratory staff. The prospect of a professional decline in laboratory medicine can be offset by increased awareness of the radical changes occurring within clinical laboratories and re-professionalization of laboratory scientists. This will require new resources to attract young professionals, and should include reaffirmation of the role of laboratory consultants and active participation in the development, implementation and monitoring of innovative diagnostic systems. The “patient” appears to be in a serious condition; it is in our hands to let him be reborn.

Clin Chem Lab Med 2006;44:913–7.


Corresponding author: Prof. Gian Cesare Guidi, MD, Istituto di Chimica e Microscopia Clinica, Dipartimento di Scienze Morfologico-Biomediche, Università degli Studi di Verona, Ospedale Policlinico G.B. Rossi, Piazzale Scuro, 10, 37134 Verona, Italy Phone: +39-045-8074308, Fax: +39-045-8201889

References

1. Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta 2002; 319:87–100.10.1016/S0009-8981(02)00028-1Search in Google Scholar

2. United States Department for Health and Human Services. The clinical laboratory workforce: the changing picture of supply, demand, education, and practice. Available at: http://bhpr.hrsa.gov/healthworkforce/reports/clinical/default.htm. Accessed April 6, 2006.Search in Google Scholar

3. Peterson LC. The crisis in America's laboratories: it's every physician's business. Med Gen Med 2005; 7:49.Search in Google Scholar

4. Pagni A, Plebani M. The laboratory and the general practitioner. Clin Chim Acta 1999; 280:13–24.10.1016/S0009-8981(98)00194-6Search in Google Scholar

5. Price CP. Medical and economic outcomes of point-of-care testing. Clin Chem Lab Med 2002; 40:246–51.10.1515/CCLM.2002.040Search in Google Scholar PubMed

6. Matsuo S. Considering what clinical laboratories should become in the future – POCT, mail testing and OTC test. Rinsho Byori 2005; 53:1159–63.Search in Google Scholar

7. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytic variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44:358–65.10.1515/CCLM.2006.073Search in Google Scholar PubMed

8. Muller MM, Hackl W, Griesmacher A. Point-of-care-testing – the intensive care laboratory. Anaesthesist 1999; 48:3–8.10.1007/s001010050661Search in Google Scholar PubMed

9. Toner M, Irimia D. Blood-on-a-chip. Annu Rev Biomed Eng 2005; 7:77–103.10.1146/annurev.bioeng.7.011205.135108Search in Google Scholar PubMed PubMed Central

10. Plebani M. Proteomics: the next revolution in laboratory medicine? Clin Chim Acta 2005; 357:113–22.10.1016/j.cccn.2005.03.017Search in Google Scholar PubMed

11. Markin RS, Whalen SA. Laboratory automation: trajectory, technology, and tactics. Clin Chem 2000; 46:764–71.10.1093/clinchem/46.5.764Search in Google Scholar

12. Bachner P. The impact of regulations, accreditation standards, and ‘healthcare reform’ on laboratory practice in the United States. Pure Appl Chem 1996; 68:1847–9.10.1351/pac199668101847Search in Google Scholar

13. Felder RA. Is lab automation right for your lab? CAP Today 2001; 15:42–4.Search in Google Scholar

14. Ricos C, Domenech MV, Perich C. Analytical quality specifications for common reference intervals. Clin Chem Lab Med 2004; 42:858–62.10.1515/CCLM.2004.140Search in Google Scholar PubMed

15. Nordin G, Martensson A, Swolin B, Sandberg S, Christensen NJ, Thorsteinsson V, et al. A multicentre study of reference intervals for haemoglobin, basic blood cell counts and erythrocyte indices in the adult population of the Nordic countries. Scand J Clin Lab Invest 2004; 64:385–98.10.1080/00365510410002797Search in Google Scholar

16. Stroobants AK, Goldschmidt HM, Plebani M. Error budget calculations in laboratory medicine: linking the concepts of biological variation and allowable medical errors. Clin Chim Acta 2003; 333:169–76.10.1016/S0009-8981(03)00181-5Search in Google Scholar

17. Panteghini M, Forest JC. Standardization in laboratory medicine: new challenges. Clin Chim Acta 2005; 355:1–12.10.1016/j.cccn.2004.12.003Search in Google Scholar PubMed

18. Jack A. Organization of neoplastic haemopathology services. A UK perspective. Pathology 2005; 37:479–92.10.1080/00313020500368360Search in Google Scholar PubMed

19. Gurwitz D, Lunshof JE, Altman RB. A call for the creation of personalized medicine databases. Nat Rev Drug Discov 2006; 5:23–6.10.1038/nrd1931Search in Google Scholar PubMed

20. Jain KK. Nanotechnology in clinical laboratory diagnostics. Clin Chim Acta 2005; 358:37–54.10.1016/j.cccn.2005.03.014Search in Google Scholar PubMed

Received: 2006-3-11
Accepted: 2006-4-18
Published Online: 2006-7-31
Published in Print: 2006-8-1

©2006 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Laboratory medicine in the 2000s: programmed death or rebirth?
  2. Polymorphisms of the inflammatory system and risk of ischemic cerebrovascular events
  3. Haptoglobin polymorphism in patients with preeclampsia
  4. Fifteen polymorphisms in endothelin-1, endothelin-2 and endothelin-receptor-A genotyped by four duplex assays and seven simple assays on a LightCycler using hybridization probes
  5. Optimization of an enzymatic method for the determination of lysosomal N-acetyl-β-D-hexosaminidase and β-glucuronidase in synovial fluid
  6. An improved laboratory protocol to assess subarachnoid haemorrhage in patients with negative cranial CT scan
  7. Association of aminothiols with the clinical outcome in hemodialysis patients: comparison of chromatography and immunoassay for homocysteine determination
  8. Poor prognosis indicated by nucleated red blood cells in peripheral blood is not associated with organ failure of the liver or kidney
  9. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium
  10. Unchanged androgen-binding properties of sex hormone-binding globulin in male patients with liver cirrhosis
  11. Relationship between serum uric acid, creatinine, albumin and gestational diabetes mellitus
  12. Aminothiols in human brain tumors
  13. Measurement of carnitine in hemodialysis patients – adaptation of an enzymatic photometric method for an automatic analyzer
  14. A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice
  15. Establishment of reference distributions and decision values for thyroid antibodies against thyroid peroxidase (TPOAb), thyroglobulin (TgAb) and the thyrotropin receptor (TRAb)
  16. Effects of a long-distance run on cardiac markers in healthy athletes
  17. α-Tocopherol supplementation reduces the elevated 8-hydroxy-2-deoxyguanosine blood levels induced by training in basketball players
  18. Influence of the needle bore size used for collecting venous blood samples on routine clinical chemistry testing
  19. The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease
  20. Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system
  21. Preliminary performance evaluation of blood gas analyzers
  22. A cost-effectiveness evaluation of reticulocyte measurement in new outpatients with or without hematologic disorders
  23. Guidelines for setting up an External Quality Assessment Scheme for blood smear interpretation. Part II: survey preparation, statistical evaluation and reporting
  24. Free light chain testing in follow-up of multiple myeloma
  25. Blood reactive oxygen metabolites (ROMs) and total antioxidant status (TAS) in patients with laryngeal squamous cell carcinoma after surgical treatment
  26. SIBioC 2006 38th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Turin, Italy, September 19–22, 2006
  27. Third Santorini Biologie Prospective Conference 2006: From Human Genetic Variations to Prediction of Risks and Responses to Drugs and the Environment, Santorini Island, Greece, September 29 - October 2, 2006
Downloaded on 8.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2006.168/html
Scroll to top button